Local Anesthesia Drugs Market Size Worth $6.45 Billion By 2025

The global local anesthesia drugs market size is anticipated to reach USD 6.45 billion by 2025, according to a new report by Grand View Research, Inc., registering a 3.7% CAGR during the forecast period. The rising number of surgical procedures across the globe, including cosmetic surgeries, dental procedures, and plastic surgeries, is driving the growth of local anesthetics.

There has been a considerable increase in the number of surgical procedures requiring post-operative pain relief and this trend is expected to continue throughout the forecast period. Roughly, 65.0% of total surgical procedures require post-operative pain management. This is likely to boost the demand for local anesthesia drugs.

The introduction of new and effective drugs such as levobupivacaine, articaine, and ropivacaine is also driving the growth of the local anesthesia drugs market across the globe. Rising healthcare expenditure in developing countries is expected to result in an increase in the number of surgeries performed in countries such as India, China, and Brazil. This is likely to contribute to market growth in the region.

 To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/local-anesthesia-drugs-market

Further key findings from the study suggest:

• Lidocaine dominated the market by product as of 2016 owing to its extensive use as a topical and injectable anesthetic

• By application, the market is bifurcated into injectable and surface anesthetic. The injectable segment is expected to dominate the local anesthesia drugs market during the forecast period owing to extensive usage in different surgical procedures. Advancements in drug delivery systems are expected to drive the market for surface anesthetics over the forecast period

• North America held the largest share in the market for local anesthesia drugs owing to a significant number of surgical procedures performed in the region

• Some of the key players are Aspen Pharmacare; Fresenius Kabi; Novartis, Inc.; Sagent Pharmaceutical; Pacira Pharmaceutical; Mylan; and Teva Pharmaceuticals.

Grand View Research has segmented the global local anesthesia drugs market on the basis of product, application, and region:

Local Anesthesia Drugs Product Outlook (Revenue, USD Million, 2014 - 2025)

• Bupivacaine

• Ropivacaine

• Lidocaine

• Chloroprocaine

• Prilocaine

• Benzocaine

• Other local anesthetics

Local Anesthesia Drugs Application Outlook (Revenue, USD Million, 2014 - 2025)

• Injectable

• Surface Anesthetic

Local Anesthesia Drugs Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America

  • The U.S.

  • Canada

• Europe

  • Germany

  • The U.K.

• Asia Pacific

  • China

  • Japan

• Latin America

  • Brazil

  • Mexico

• MEA

  • South Africa